IN-VIVO MONOAMINE RELEASE DURING NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL

被引：18
|
作者：
SILVERSTONE, PH
DONE, C
SHARP, T
机构：
[1] MACKENZIE CTR,DEPT PSYCHIAT,EDMONTON T6G 2B7,AB,CANADA
[2] UNIV OXFORD,RADCLIFFE INFIRM,DEPT CLIN PHARMACOL,OXFORD OX2 6HE,ENGLAND
来源：
NEUROREPORT | 1993年 / 4卷 / 08期
关键词：
MORPHINE-WITHDRAWAL; NORADRENALINE; 5-HYDROXYTRYPTAMINE; DOPAMINE; MICRODIALYSIS;
D O I：
10.1097/00001756-199308000-00012
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
THERE is much evidence from animal work suggesting that the release of noradrenaline (NA) in the brain increases during naloxone-precipitated morphine withdrawal, but the evidence in favour of changes in release of 5-hydroxytryptamine (5-HT) and dopamine (DA) is contradictory. Here we demonstrate, using in vivo microdialysis, that whilst there is a considerable increase (300%) in release of NA in hippocampus precipitated by naloxone in morphine-dependent rats, there is no change in the release of either 5-HT (in hippocampus) or DA (in nucleus accumbens). These results are consistent with suggestions that the symptoms of morphine withdrawal in rats are due primarily to an increase in central NA release.
引用
收藏
页码：1043 / 1045
页数：3
相关论文
共 50 条
  • [31] Modification by muscimol of naloxone-precipitated withdrawal symptoms in morphine-dependent mice
    ElKadi, AOS
    Sharif, SI
    GENERAL PHARMACOLOGY, 1995, 26 (07): : 1579 - 1581
  • [32] EFFECTS OF CHRONIC TREATMENT WITH DIAZEPAM, PHENOBARBITAL, OR AMPHETAMINE ON NALOXONE-PRECIPITATED MORPHINE WITHDRAWAL
    EISENBERG, RM
    DRUG AND ALCOHOL DEPENDENCE, 1985, 15 (04) : 375 - 381
  • [33] Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice
    Samini, M
    Fakhrian, R
    Mohagheghi, M
    Dehpour, AR
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2000, 15 (02) : 95 - 101
  • [34] Functional magnetic resonance neuroimaging of drug dependence: Naloxone-precipitated morphine withdrawal
    Lowe, AS
    Williams, SCR
    Symms, MR
    Stolerman, IP
    Shoaib, M
    NEUROIMAGE, 2002, 17 (02) : 902 - 910
  • [35] ANANDAMIDE DECREASES NALOXONE-PRECIPITATED WITHDRAWAL SIGNS IN MICE CHRONICALLY TREATED WITH MORPHINE
    VELA, G
    RUIZGAYO, M
    FUENTES, JA
    NEUROPHARMACOLOGY, 1995, 34 (06) : 665 - 668
  • [36] Naloxone-precipitated morphine withdrawal induced place aversions: Effect of naloxone at 24 hours postmorphine
    Parker, LA
    Joshi, A
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 61 (03) : 331 - 333
  • [37] Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice
    Diaz, Silvina L.
    Hermida, Maria P.
    Joannas, Leonel D.
    Olivera, Monica
    Ridolfi, Adriana
    Villaamil, Edda C.
    Balerio, Graciela N.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) : 283 - 289
  • [38] Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs
    Tan, PPC
    Chen, JC
    Li, JY
    Liang, KW
    Wong, CH
    Huang, EYK
    PEPTIDES, 1999, 20 (10) : 1211 - 1217
  • [39] Effect of memantine on morphine physical dependence in acute naloxone-precipitated withdrawal.
    Aricioglu, Feyza
    Gocmez, Selcen
    Mutlu, Oguz
    Utkan, Tijen
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 421 - 422
  • [40] Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP
    Bajo, Michal
    Madamba, Samuel G.
    Roberto, Marisa
    Siggins, George R.
    FRONTIERS IN INTEGRATIVE NEUROSCIENCE, 2014, 8
12345